Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04586998
Other study ID # HC-G-H-1716
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date April 2021
Est. completion date July 2022

Study information

Verified date May 2021
Source B. Braun Melsungen AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Edmon is the first Communauté Européenne (CE) marked medical device able to continuously measure propofol in the exhaled breath of patients under sedation or anaesthesia with propofol. Current scientific publications indicate that it makes sense from a pharmacologic point of view to measure propofol in the exhaled air. If the present study can show the Edmon to be able to detect small differences in propofol plasma concentration it will underline the clinical value of measuring propofol in the exhaled breath. This might be an opportunity for a significant improvement in patient monitoring.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 2022
Est. primary completion date July 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Inclusion criteria - Male or female patients undergoing elective surgical procedures - Expected duration of the surgical procedure > 1h - General anaesthesia (TIVA) with propofol and remifentanil under orotracheal intubation - Medical need for an arterial line for an invasive haemodynamic monitoring during anaesthesia - Written informed consent - Age = 18 years - ASA I-III - BMI < 35 kg/m² - Women of child bearing potential: negative pregnancy test - BIS monitoring feasible (e.g. no surgical procedures on the frontal brain) - The patient is expected to be extubated in the OR after end of surgery - Exclusion criteria - Patients with contraindications for propofol, remifentanil or for the planned anaesthetic procedure - Cardiac surgery - Lung surgery - Organ transplant procedures - Pulmonary diffusion anomalies (e.g. pulmonary fibrosis), known from medical history - Patients on renal replacement therapy - Participation in another interventional trial - Breastfeeding women - Unilateral lung ventilation - Emergency surgery - Patient is not able to give his/her written informed consent - Patients with a haemoglobin level below 10 g/dl

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Exhaled drug monitor "Edmon"
Taking samples of exhaled breath every minute during elective surgery in comparison to blood samples taken at predefined time points.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
B. Braun Melsungen AG

Outcome

Type Measure Description Time frame Safety issue
Primary Propofol measurements To investigate the correlation between propofol concentrations in exhaled breath and blood plasma in patients undergoing elective surgical procedures under total intravenous anaesthesia. During elective surgical procedure lasting longer than 1 hour
Secondary Identification of confounders with an impact on propofol exhaled breath concentration, e.g.among ventilatory and circulatory parameters To identify confounders among ventilatory and circulatory parameters by correlating the course of propofol values with courses of single parameters from vital sign monitor or anaesthetic machine (e.g. systolic blood pressure or positive end-expiratory pressure (PEEP)) During elective surgical procedure lasting longer than 1 hour
Secondary Evaluation of the correlation between propofol exhaled breath concentration and EEG index values For that correlation EEG index values (Bispectral index (BIS) and suppression ratio) will be corrected by calculated remifentanil plasma concentration and then correlated to propofol exhaled breath concentrations During elective surgical procedure lasting longer than 1 hour
See also
  Status Clinical Trial Phase
Completed NCT03861364 - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose. Phase 4
Not yet recruiting NCT06092684 - The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery Phase 3
Not yet recruiting NCT04266535 - TCI vs Manually Controlled Infusion of Propofol
Recruiting NCT03864094 - Hemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine. Phase 4
Not yet recruiting NCT06237101 - Remifentanil Effect on Burst Suppression Ratio N/A
Completed NCT03861377 - Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses. Phase 4
Completed NCT02492282 - Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System Phase 3
Completed NCT03661489 - Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery Phase 3
Completed NCT02197858 - Comparability of Invasive and Non-invasive Haemodynamic Monitoring N/A
Recruiting NCT03428191 - Target Effect-site Concentration of Remifentanil in Transperineal Prostate Puncture N/A
Completed NCT02527083 - Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain Phase 4
Completed NCT01531491 - Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol N/A
Recruiting NCT00378170 - Laryngoscope Prototype Tested Against the Traditional Macintosh Blade N/A
Completed NCT03614325 - Virtual Reality in the Operating Room N/A
Completed NCT05047939 - Comparison of Recovery Profile After TIVA Between Remimazolam With Flumazenil and Propofol N/A
Completed NCT02706431 - Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients N/A
Active, not recruiting NCT05343260 - Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery N/A
Completed NCT02660411 - Impact of Anesthesia Maintenance Methods on Long-term Survival N/A